Literature DB >> 24115241

CCAAT/enhancer-binding protein β expressed by bone marrow mesenchymal stromal cells regulates early B-cell lymphopoiesis.

Satoshi Yoshioka1, Yasuo Miura, Hisayuki Yao, Sakiko Satake, Yoshihiro Hayashi, Akihiro Tamura, Terutoshi Hishita, Tatsuo Ichinohe, Hideyo Hirai, Akifumi Takaor-Kondo, Taira Maekawa.   

Abstract

The transcription factor CCAAT/enhancer-binding protein β (C/EBPβ) regulates the differentiation of a variety of cell types. Here, the role of C/EBPβ expressed by bone marrow mesenchymal stromal cells (BMMSCs) in B-cell lymphopoiesis was examined. The size of the precursor B-cell population in bone marrow was reduced in C/EBPβ-knockout (KO) mice. When bone marrow cells from C/EBPβ-KO mice were transplanted into lethally irradiated wild-type (WT) mice, which provide a normal bone marrow microenvironment, the size of the precursor B-cell population was restored to a level equivalent to that generated by WT bone marrow cells. In coculture experiments, BMMSCs from C/EBPβ-KO mice did not support the differentiation of WT c-Kit(+) Sca-1(+) Lineage(-) hematopoietic stem cells (KSL cells) into precursor B cells, whereas BMMSCs from WT mice did. The impaired differentiation of KSL cells correlated with the reduced production of CXCL12/stromal cell-derived factor-1 by the cocultured C/EBPβ-deficient BMMSCs. The ability of C/EBPβ-deficient BMMSCs to undergo osteogenic and adipogenic differentiation was also defective. The survival of leukemic precursor B cells was poorer when they were cocultured with C/EBPβ-deficient BMMSCs than when they were cocultured with WT BMMSCs. These results indicate that C/EBPβ expressed by BMMSCs plays a crucial role in early B-cell lymphopoiesis.
© 2013 AlphaMed Press.

Entities:  

Keywords:  B lymphocytes; Bone marrow; CCAAT/enhancer-binding protein β; Mesenchymal stromal cells

Mesh:

Substances:

Year:  2014        PMID: 24115241     DOI: 10.1002/stem.1555

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  9 in total

1.  Bortezomib interferes with adhesion of B cell precursor acute lymphoblastic leukemia cells through SPARC up-regulation in human bone marrow mesenchymal stromal/stem cells.

Authors:  Masaki Iwasa; Yasuo Miura; Aya Fujishiro; Sumie Fujii; Noriko Sugino; Satoshi Yoshioka; Asumi Yokota; Terutoshi Hishita; Hideyo Hirai; Akira Andoh; Tatsuo Ichinohe; Taira Maekawa
Journal:  Int J Hematol       Date:  2017-01-02       Impact factor: 2.490

Review 2.  C/EBPß Isoform Specific Gene Regulation: It's a Lot more Complicated than you Think!

Authors:  Aaron J Spike; Jeffrey M Rosen
Journal:  J Mammary Gland Biol Neoplasia       Date:  2020-02-20       Impact factor: 2.673

3.  Isolation of mesenchymal stromal/stem cells from small-volume umbilical cord blood units that do not qualify for the banking system.

Authors:  Satoshi Yoshioka; Yasuo Miura; Masaki Iwasa; Aya Fujishiro; Hisayuki Yao; Masako Miura; Masaaki Fukuoka; Yoko Nakagawa; Asumi Yokota; Hideyo Hirai; Tatsuo Ichinohe; Akifumi Takaori-Kondo; Taira Maekawa
Journal:  Int J Hematol       Date:  2015-06-30       Impact factor: 2.490

Review 4.  Human bone marrow mesenchymal stromal/stem cells: current clinical applications and potential for hematology.

Authors:  Yasuo Miura
Journal:  Int J Hematol       Date:  2015-12-21       Impact factor: 2.490

5.  Comparative analyses of industrial-scale human platelet lysate preparations.

Authors:  Jan Pierce; Eric Benedetti; Amber Preslar; Pam Jacobson; Ping Jin; David F Stroncek; Jo-Anna Reems
Journal:  Transfusion       Date:  2017-10-08       Impact factor: 3.157

6.  Non-steady-state hematopoiesis regulated by the C/EBPβ transcription factor.

Authors:  Hideyo Hirai; Asumi Yokota; Akihiro Tamura; Atsushi Sato; Taira Maekawa
Journal:  Cancer Sci       Date:  2015-06-01       Impact factor: 6.716

Review 7.  Interaction between Mesenchymal Stem Cells and B-Cells.

Authors:  Linxiao Fan; Chenxia Hu; Jiajia Chen; Panpan Cen; Jie Wang; Lanjuan Li
Journal:  Int J Mol Sci       Date:  2016-05-05       Impact factor: 5.923

8.  The role of growth differentiation factor 15 in the pathogenesis of primary myelofibrosis.

Authors:  Tatsuki Uchiyama; Hiroshi Kawabata; Yasuo Miura; Satoshi Yoshioka; Masaki Iwasa; Hisayuki Yao; Soichiro Sakamoto; Masakazu Fujimoto; Hironori Haga; Norimitsu Kadowaki; Taira Maekawa; Akifumi Takaori-Kondo
Journal:  Cancer Med       Date:  2015-08-15       Impact factor: 4.452

Review 9.  Pharmacological targeting of bone marrow mesenchymal stromal/stem cells for the treatment of hematological disorders.

Authors:  Noriko Sugino; Tatsuo Ichinohe; Akifumi Takaori-Kondo; Taira Maekawa; Yasuo Miura
Journal:  Inflamm Regen       Date:  2017-04-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.